These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 5690393)

  • 1. Polyglucosans in the systemic deposits of myoclonic epilepsy and in corpora amylacea.
    Sakai M; Austin J; Witmer F
    Neurology; 1968 Mar; 18(3):298. PubMed ID: 5690393
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies in myoclonus epilepsy (Lafora body form). II. Polyglucosans in the systemic deposits of myoclonus epilepsy and in corpora amylacea.
    Sakai M; Austin J; Witmer F; Trueb L
    Neurology; 1970 Feb; 20(2):160-76. PubMed ID: 4188951
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies in myoclonus epilepsy (Lafora body form). I. Isolation and preliminary characterization of Lafora bodies in two cases.
    Yokoi S; Austin J; Witmer F; Sakai M
    Arch Neurol; 1968 Jul; 19(1):15-33. PubMed ID: 4175641
    [No Abstract]   [Full Text] [Related]  

  • 4. Myoclonus epilepsy with Lafora bodies. An ultrastruc- tural and cytochemical study.
    Collins GH; Cowden RR; Nevis AH
    Arch Pathol; 1968 Sep; 86(3):239-54. PubMed ID: 4877594
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biochemical studies in progressive myoclonus epilepsy (Lafora body form)--extraction and structure of glycogen].
    Osuka T; Yokoi S
    Seishin Shinkeigaku Zasshi; 1971 Jul; 73(7):557-64. PubMed ID: 5106989
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation and characterization of Lafora bodies in two cases of myoclonus epilepsy.
    Yokoi S; Austin J; Witmer F
    J Neuropathol Exp Neurol; 1967 Jan; 26(1):125-7. PubMed ID: 4164450
    [No Abstract]   [Full Text] [Related]  

  • 7. Presenile dementia with "Lafora-like" intraneuronal inclusions.
    Suzuki K; David E; Kutschman B
    Arch Neurol; 1971 Jul; 25(1):69-80. PubMed ID: 4111956
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies of corpora amylacea. I. Isolation and preliminary characterization by chemical and histochemical techniques.
    Sakai M; Austin J; Witmer F; Trueb L
    Arch Neurol; 1969 Nov; 21(5):526-44. PubMed ID: 5344361
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral lipid composition in infantile Gaucher's disease (IGD).
    French JH; Brotz M; Poser CM
    Neurology; 1968 Mar; 18(3):301. PubMed ID: 5690402
    [No Abstract]   [Full Text] [Related]  

  • 10. G5-ganglioside variant of systemic late infantile lipidosis. Generalized gangliosidosis.
    Volk BW; Adachi M; Schneck L; Saifer A; Kleinberg W
    Arch Pathol; 1969 Apr; 87(4):393-403. PubMed ID: 5766766
    [No Abstract]   [Full Text] [Related]  

  • 11. Corpora amylacea: Isolation, characterization, and significance.
    Sakai M; Austin J; Witmer F; Trueb L
    Trans Am Neurol Assoc; 1969; 94():336-8. PubMed ID: 5374480
    [No Abstract]   [Full Text] [Related]  

  • 12. Biochemical studies on tissues from a patient with Lafora disease.
    Yokoi S; Nakayama H; Negishi T
    Clin Chim Acta; 1975 Aug; 62(3):415-23. PubMed ID: 170019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progressive myoclonus epilepsy with Lafora inclusion bodies. I. Clinical, genetic, histopathologic, and biochemical aspects.
    Janeway R; Ravens JR; Pearce LA; Odor DL; Suzuki K
    Arch Neurol; 1967 Jun; 16(6):565-82. PubMed ID: 6026066
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies in myoclonus epilepsy. 3. The effects of amylolytic enzymes on the ultrastructure of Lafora bodies.
    Nikaido T; Austin J; Stukenbrok H
    J Histochem Cytochem; 1971 Jun; 19(6):382-5. PubMed ID: 4104134
    [No Abstract]   [Full Text] [Related]  

  • 15. Macular cherry-red spot, myoclonic epilepsy, and neurovisceral storage in a 17-year-old girl.
    Goldstein ML; Kolodny EH; Gascon GG; Gilles FH
    Trans Am Neurol Assoc; 1974; 99():110-2. PubMed ID: 4463520
    [No Abstract]   [Full Text] [Related]  

  • 16. [Central nervous system deposits in protractive (Lundborg-type myoclonic bodies disease].
    Jakob H
    Acta Neuropathol; 1969; 12(3):260-75. PubMed ID: 5792203
    [No Abstract]   [Full Text] [Related]  

  • 17. The localization and origin of carbohydrate-protein complexes in macrophages.
    Hawrylko EA; Cohn ZA
    Lab Invest; 1968 Oct; 19(4):421-7. PubMed ID: 5699123
    [No Abstract]   [Full Text] [Related]  

  • 18. [Tapetoretinal degeneration, deafness, myoclonus, dementia, epilepsy with the presence of excess alpha-amino-n-butyric acid. Contribution to the study of leptomeningeal angiomatosis with leukodystrophy sudanophil and abiotrophic complexes].
    Martin L; Martin JJ; Guazzi GC; Lowenthal A; Maniewski J
    J Neurol Sci; 1968; 6(2):217-36. PubMed ID: 4180009
    [No Abstract]   [Full Text] [Related]  

  • 19. [Biochemical study of humus and para-humic substances of microbial synthesis as a function of their molecular weight].
    Robert-Gero ; Hardisson C; Le Borgne L; Pignaud G
    Ann Inst Pasteur (Paris); 1966 Dec; 111(6):750-67. PubMed ID: 5982751
    [No Abstract]   [Full Text] [Related]  

  • 20. Atypical myoclonus body epilepsy (adult variant).
    Dolman CL
    Acta Neuropathol; 1975; 31(3):201-6. PubMed ID: 124526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.